Intensive glycemic control in type 2 diabetes mellitus - A balancing act of latent benefit and avoidable harm a teachable moment

JAMA Internal Medicine

Volumn 176, Issue 3, 2016, Pages 300-301

  Rodriguez Gutierrez, Rene ^a,b   Lipska, Kasia J ^c   McCoy, Rozalina G ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIMEPIRIDE; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN; SITAGLIPTIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; BEDTIME DOSAGE; CASE REPORT; DYSLIPIDEMIA; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; LIFESTYLE MODIFICATION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; ANXIETY; BLOOD; CHEMICALLY INDUCED; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ETIOLOGY; GLUCOSE BLOOD LEVEL; METABOLISM; PATIENT CARE; PATIENT PARTICIPATION; PREVENTION AND CONTROL; PSYCHOLOGY;

ANXIETY; BIOMARKERS; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT PARTICIPATION;

EID: 84962173515     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.8320     Document Type: Note

References (5)

1. Montori VM, Fernández-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med. 2009; 150(11):803-808.
2. Hemmingsen B, Lund SS, Gluud C, et al Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013; 11:CD008143.
3. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes. Endocr Pract. 2013; 19(5):792-799.
4. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012; 35(9):1897-1901.
5. Tamhane S, Rodriguez-Gutierrez R, Hargraves I., Montori VM. Shared decision-making in diabetes care. Curr Diab Rep. 2015; 15(12):112.